Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CL.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BR.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.132 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.83EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDGEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCSEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.15.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KB.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CJ.1.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XANEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EU.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JB.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.256EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.77EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.248EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.70EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.559EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.406EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used